相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of Dapagliflozin on Urine Metabolome in Patients with Type 2 Diabetes
Evdoxia Bletsa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino et al.
EUROPEAN HEART JOURNAL (2020)
METHYLGLYOXAL, A HIGHLY REACTIVE DICARBONYL COMPOUND, IN DIABETES, ITS VASCULAR COMPLICATIONS, AND OTHER AGE-RELATED DISEASES
C. G. Schalkwijk et al.
PHYSIOLOGICAL REVIEWS (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients
Aino Latva-Rasku et al.
DIABETES CARE (2019)
Branched-chain amino acids in disease
Phillip J. White et al.
SCIENCE (2019)
Effects of dapagliflozin on urinary metabolites in people with type 2 diabetes
Skander Mulder et al.
DIABETES OBESITY & METABOLISM (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Betaine increases mitochondrial content and improves hepatic lipid metabolism
Lifang Zhang et al.
FOOD & FUNCTION (2019)
Effect of renal tubule-specific knockdown of the Na+/H+ exchanger NHE3 in Akita diabetic mice
Akira Onishi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice
Dustin M. Lee et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Impairing L-Threonine Catabolism Promotes Healthspan through Methylglyoxal-Mediated Proteohormesis
Meenakshi Ravichandran et al.
CELL METABOLISM (2018)
Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy
Robert Martinez et al.
DIABETES (2018)
Mitochondrial dysfunction in diabetic kidney disease
Josephine M. Forbes et al.
NATURE REVIEWS NEPHROLOGY (2018)
Diabetes and branched-chain amino acids: What is the link?
Zachary Bloomgarden
JOURNAL OF DIABETES (2018)
Betaine in inflammation: Mechanistic Aspects and Applications
Guangfu Zhao et al.
FRONTIERS IN IMMUNOLOGY (2018)
Urine Tricarboxylic Acid Cycle Metabolites Predict Progressive Chronic Kidney Disease in Type 2 Diabetes
Jian-Jun Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Metabolomics applied to diabetes - lessons from human population studies
Sonia Liggi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)
Mechanisms linking empagliflozin to cardiovascular and renal protection
Pasquale Perrone-Filardi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Short-chain acyl-CoA dehydrogenase deficiency: from gene to cell pathology and possible disease mechanisms
Zahra Nochi et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effect of Empagliflozin on the Metabolic Signature of Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease
Ben A. Kappel et al.
CIRCULATION (2017)
Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease
Farsad Afshinnia et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
Is N,N-dimethylglycine N-oxide a choline and betaine metabolite?
Michael Lever et al.
BIOLOGICAL CHEMISTRY (2017)
Renal Handling of Ketones in Response to Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes
Ele Ferrannini et al.
DIABETES CARE (2017)
Metabolomics and Metabolic Diseases: Where Do We Stand?
Christopher B. Newgard
CELL METABOLISM (2017)
Dietary Betaine Supplementation Increases Fgf21 Levels to Improve Glucose Homeostasis and Reduce Hepatic Lipid Accumulation in Mice
Asma Ejaz et al.
DIABETES (2016)
Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes
Ele Ferrannini et al.
DIABETES (2016)
CV Protection in the EMPA-REG OUTCOME Trial: A Thrifty Substrate Hypothesis
Ele Ferrannini et al.
DIABETES CARE (2016)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Metabonomic study of biochemical changes in urinary of type 2 diabetes mellitus patients after the treatment of sulfonylurea antidiabetic drugs based on ultra-performance liquid chromatography/mass spectrometry
Taoguang Huo et al.
BIOMEDICAL CHROMATOGRAPHY (2015)
Renal depletion of myo-inositol is associated with its increased degradation in animal models of metabolic disease
H. -H. Chang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
Volker Vallon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Nicotinuric Acid A potential marker of metabolic syndrome through a metabolomics-based approach
Chun-Feng Huang et al.
DIABETES CARE (2013)
Protective effect of an intrinsic antioxidant, HMH (5-hydroxy-1-methylhydantoin; NZ-419), against cellular damage of kidney tubules
Kazuharu Ienaga et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2013)
2-Aminoadipic acid is a biomarker for diabetes risk
Thomas J. Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Hippurate: The Natural History of a Mammalian-Microbial Cometabolite
Hannah J. Lees et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Trigonelline ameliorates diabetic hypertensive nephropathy by suppression of oxidative stress in kidney and reduction in renal cell apoptosis and fibrosis in streptozotocin induced neonatal diabetic (nSTZ) rats
Arvindkumar E. Ghule et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Serum accumulation of a creatinine oxidative metabolite (NZ-419: 5-hydroxy-1-methylhydatoin) as an intrinsic antioxidant in diabetic patients with or without chronic kidney disease
G. Hasegawa et al.
CLINICAL NEPHROLOGY (2011)
Transcriptional and Post-translational Modulation of myo-Inositol Oxygenase by High Glucose and Related Pathobiological Stresses
Baibaswata Nayak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
icoshift: A versatile tool for the rapid alignment of 1D NMR spectra
F. Savorani et al.
JOURNAL OF MAGNETIC RESONANCE (2010)
α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population
Walter E. Gall et al.
PLOS ONE (2010)
CV-ANOVA for significance testing of PLS and OPLS® models
Lennart Eriksson et al.
JOURNAL OF CHEMOMETRICS (2008)
High glucose inhibits renal proximal tubule cell proliferation and involves PKC, oxidative stress, and TGF-β1
SH Park et al.
KIDNEY INTERNATIONAL (2001)
分享论文
